Tests probiotic capsules for atrial fibrillation returning after cardioversion
Tests probiotic capsules in adults having cardioversion for atrial fibrillation.
Plain-language title generated from the registry record
Registry title: Evaluation of Probiotics' Effect on Atrial Fibrillation Recurrence in Patients Undergoing Cardioversion
Key facts
- Where
- Cairo, EgyptSee the site
Where in Egypt
- Ain Shams University's HospitalCairo, EgyptNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Ain Shams University
- Trial code
- NCT07568964
- Record updated
- 6 May 2026
- Original description
The aim of this clinical study is to evaluate the efficacy and tolerability of probiotics on atrial fibrillation recurrence.Read full original descriptionShow less
Effect of Probiotics on Atrial Fibrillation Outcome in Patients Undergoing Cardioversion
The aim of this clinical study is to evaluate the efficacy and tolerability of probiotics on atrial fibrillation recurrence.
Inclusion: Female or male aged 40 years or above with BMI less than 40; Persistent AF patients directly after cardioversion.
Exclusion: History of probiotic supplementation in the previous 6 weeks; Ongoing treatment with immunosuppressive therapies; Autoimmune diseases; Active Infection; History of or known allergy or intolerability to the study medications; Pregnant or breast-feeding patients; Active participation in another clinical study.